Premium Nahrungsergänzungsmittel | artgerecht

Jejunal Mucosal Markers - Meaning and Diagnosis

Jejunal mucosal markers are diagnostic parameters used to assess the condition of the small intestinal lining in the jejunum, playing a key role in diagnosing diseases such as celiac disease.

Regular tips about health Regular tips about health

Things worth knowing about "Jejunal mucosal markers"

Jejunal mucosal markers are diagnostic parameters used to assess the condition of the small intestinal lining in the jejunum, playing a key role in diagnosing diseases such as celiac disease.

What Are Jejunal Mucosal Markers?

Jejunal mucosal markers are diagnostic parameters that describe the structural and functional condition of the mucosal lining (mucosa) of the jejunum. The jejunum is the middle segment of the small intestine and plays a central role in the absorption of nutrients, vitamins, and minerals. Changes in the jejunal mucosa can indicate a wide range of conditions and are assessed using histological, serological, and endoscopic methods.

Clinical Importance

Evaluating the jejunal mucosa is particularly important in diagnosing diseases associated with damage or changes to the small intestinal lining. The main clinical areas of application include:

Celiac disease: A gluten-induced autoimmune condition characterized by destruction of intestinal villi (villous atrophy) in the jejunum.
Crohn's disease: A chronic inflammatory bowel disease that can affect all segments of the gastrointestinal tract, including the jejunum.
Tropical sprue: A malabsorption disease also associated with mucosal changes in the jejunum.
Autoimmune enteropathy: A rare condition involving antibodies against enterocytes and pronounced mucosal changes.
Parasitic infections: Pathogens such as Giardia lamblia can also damage the jejunal mucosa.

Types of Jejunal Mucosal Markers

Histological Markers

Histological examination of tissue samples (biopsies) from the jejunum is the gold standard for assessing the mucosa. Key histological markers include:

Villous height-to-crypt depth ratio (villus-to-crypt ratio): Indicates the relationship between the length of the intestinal villi and the depth of the crypts. A reduced ratio points to villous atrophy.
Intraepithelial lymphocyte index (IEL): The number of lymphocytes within the surface epithelium per 100 enterocytes. Elevated IEL counts are an early sign of mucosal damage.
Crypt hyperplasia: A reactive enlargement of the crypts in response to mucosal damage.
Marsh classification: A standardized scoring system for grading the extent of mucosal changes in celiac disease (Marsh 0 to Marsh 3).

Serological Markers

Certain blood parameters can indirectly indicate changes in the jejunal mucosa:

Tissue transglutaminase antibodies (tTG-IgA): A highly specific and sensitive marker for celiac disease.
Endomysial antibodies (EMA-IgA): Also specific for celiac disease and correlates with the degree of villous atrophy.
Deamidated gliadin peptide antibodies (DGP): Particularly useful in patients with IgA deficiency.
Intestinal fatty acid-binding protein (I-FABP): A marker for acute enterocyte damage that is released into the bloodstream when the mucosal lining is injured.

Functional Markers

Functional tests provide information about the absorptive capacity of the jejunum:

D-xylose test: Measures the absorptive ability of the proximal small intestine. Reduced results indicate significant mucosal damage.
Lactose tolerance test: Evaluates lactase activity in the small intestine.
Stool parameters: Elevated fecal fat or reduced fecal elastase may indicate malabsorption.

Diagnosis and Examination Methods

Various methods are used to assess the jejunal mucosa:

Endoscopy with biopsy: Collection of tissue samples from the duodenum and jejunum is the gold standard. At least four to six biopsies are taken from the distal duodenum and, when indicated, from the jejunum.
Capsule endoscopy: Allows non-invasive visualization of the entire small intestinal mucosa, including the jejunum.
Imaging methods: MRI or CT enterography for assessing transmural changes and the extent of inflammation.
Serological blood tests: Screening for disease-specific antibodies as an initial diagnostic step.

Treatment for Pathological Mucosal Markers

Treatment is directed at the underlying condition:

Celiac disease: A lifelong gluten-free diet typically leads to complete mucosal regeneration.
Crohn's disease: Use of immunosuppressants, biologics, and surgical intervention if necessary.
Infections: Antibiotic or antiparasitic therapy depending on the pathogen.
Nutritional therapy: Correction of deficiencies through targeted supplementation of iron, folate, vitamin B12, and other micronutrients.

References

Ludvigsson JF, Leffler DA, Bai JC, et al. - The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43-52.
Oberhuber G, Granditsch G, Vogelsang H. - The histopathology of coeliac disease: time for a standardized report scheme for pathologists. European Journal of Gastroenterology and Hepatology. 1999;11(10):1185-1194.
World Gastroenterology Organisation (WGO) - Global Guidelines: Celiac Disease. 2016. Available at: https://www.worldgastroenterology.org

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.